Bb. Ruzicka et H. Akil, DIFFERENTIAL CELLULAR-REGULATION OF PROOPIOMELANOCORTIN BY INTERLEUKIN-1-BETA AND CORTICOTROPIN-RELEASING HORMONE, Neuroendocrinology, 61(2), 1995, pp. 136-151
Considerable evidence supports the existence of a bidirectional commun
ication between the immune system and the hypothalamo-pituitary-adrena
l (HPA) axis. In the present study, we examined the interleukin-1 beta
(IL1 beta)-mediated regulation of pro-opiomelanocortin (POMC) at a ce
llular level, from secretion to gene expression, using murine anterior
pituitary corticotroph tumor (AtT20) cells as a model system. The reg
ulatory effects of IL1 beta were compared to those of the classical PO
MC regulator, corticotropin-releasing hormone (CRH). IL1 beta was foun
d to evoke an early, preferential release of beta-lipotropin (beta LPH
) which was accompanied by elevations in POMC heteronuclear (hn)RNA an
d c-fos and c-jun mRNAs. IL1 beta also elicited a late, preferential r
elease of beta LPH which was associated with only an enhanced expressi
on of POMC hnRNA. Additionally, IL1 beta stimulated an intermediate, p
referential release of beta-endorphin (beta E) which was not accompani
ed by any changes in gene expression. In marked contrast to IL1 beta,
CRH evoked an early, preferential beta E secretory response which was
associated with elevations in POMC hnRNA and c-fos mRNA. CRH also elic
ited a late, preferential beta E release which was associated with onl
y an enhanced POMC hnRNA expression. These findings show that although
both IL1 beta and CRH activate the corticotrophs, they elicit dramati
cally different patterns in the regulation of the biochemical dynamics
of POMC. Such distinct patterns of corticotroph activation in respons
e to IL1 beta or CRH exposure in vivo would allow the pituitary not on
ly to indicate that it has been activated, but also how it has been ac
tivated. This characteristic may be critically important in the functi
on of the HPA axis and in the interaction of the HPA axis with the imm
une system.